Cadila Healthcare receives Establishment Inspection Report for Ankleshwar (Unit 1) facility
From USFDA
Cadila Healthcare's API manufacturing facility located at Ankleshwar (Unit 1), Gujarat has received an Establishment Inspection Report (EIR). The USFDA had conducted an inspection at the facility from 22 to 26 July 2019. The EIR report stated that the classification of the facility is 'No Action Indicated (NAI)Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 23 2019 | 4:21 PM IST